Table 3.
Characteristic at baseline | Control % (n) |
HIPPO-ST % (n) |
---|---|---|
Sociodemographics | ||
Mean age (yr) | 53.00 | 58.41 |
Sex | ||
Male | 58.8 (20) | 64.5 (20) |
Female | 41.2 (14) | 35.5 (11) |
Ethnicity | ||
White | 63.6 (21) | 61.3 (19) |
Black | 6.1 (2) | 12.9 (4) |
East Asian | 18.2 (6) | 12.9 (4) |
South Asian | 12.1 (4) | 12.9 (4) |
Comorbidities | ||
Hypertension | 64.7 (22) | 80.6 (25) |
Diabetes | 55.9 (19) | 61.3 (19) |
Peripheral vascular disease | 8.8 (3) | 6.5 (2) |
Coronary artery disease | 32.4 (11) | 38.7 (12) |
Congestive heart failure | 26.5 (9) | 22.6 (7) |
Stroke | 8.8 (3) | 9.7 (3) |
Gastric bleeding | 15.2 (5) | 0.0 (0) |
Chronic obstructive pulmonary disease | 0.0 (0) | 3.3 (1) |
Malignancy | 26.9 (7) | 16.0 (4) |
Chronic skin condition | 11.8 (4) | 6.5 (2) |
Other conditionsa | 54.5 (18) | 48.4 (15) |
Catheter characteristics | ||
Mean length of follow up (catheter days) | 167 | 172 |
Previous catheter use | 67.9 (19) | 52.2 (12) |
Some other comorbidities included psychiatric disorders, rheumatologic conditions, gastrointestinal disorders, head injury, intracranial hemorrhage, and hematologic conditions.